The Senate on Thursday passed a bill (S 2925) that would assist minors who are victims of sex trafficking and provide state and local grants aimed at bringing offenders to court, CQ Today reports…
No Comments »
Filed under: Women's Health
‘Nexplanon’ ® (etonogestrel implant 68mg) has been accepted by the Scottish Medicines Consortium (SMC) for use in NHS Scotland as a long acting reversible contraceptive (LARC). 1 The subdermal implant is inserted just under the skin of a woman’s upper arm…
No Comments »
Filed under: Women's Health
Research published in Nature Genetics identifies two genetic variants that increase the risk of developing endometriosis, a gynaecological disease which is estimated to affect 6 to 10 per cent of all women in their reproductive years…
No Comments »
Filed under: Women's Health
WASHINGTON (MedPage Today) — All lots of several antacid products by Johnson & Johnson subsidiary McNeil Consumer Healthcare have been voluntarily recalled following complaints of debris in the drugs.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — All lots of several antacid products by Johnson & Johnson subsidiary McNeil Consumer Healthcare have been voluntarily recalled following complaints of debris in the drugs.
No Comments »
Filed under: Pharmacy News
Inhibitex, Inc. today reported top-line safety and efficacy data from its Phase II clinical trial of FV-100, an oral antiviral compound being developed to treat herpes zoster, more commonly referred to as shingles. The study was the first clinical trial to assess the antiviral activity of FV-100, included 350 shingles patients and compared two once-daily [...]
No Comments »
Filed under: Pharmacy News
Capstone Therapeutics announced today twelve-month results from its two AZX100 Phase 2a pilot clinical trials in keloid scarring and seven-month interim results of its ongoing AZX100 Phase 2a pilot clinical trial in surgical (trocar site) scarring.
No Comments »
Filed under: Pharmacy News
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company’s supplemental New Drug Application (sNDA) for DEFINITY® (Perflutren Lipid Microsphere) Injectable Suspension for use in stress echocardiography.
No Comments »
Filed under: Pharmacy News
Eli Lilly and Company announced today that it has suspended its global Phase III study evaluating tasisulam, an investigational, small-molecule anti-cancer compound, as a second-line treatment for those with unresectable or metastatic melanoma.
No Comments »
Filed under: Pharmacy News
Tibotec Therapeutics, a division of Centocor Ortho Biotech Products, L.P., announced today that the U.S. Food and Drug Administration (FDA) has approved a revision to the dosing recommendation to include once-daily dosing of PREZISTA® (darunavir) tablets in combination with ritonavir for the treatment of human immunodeficiency virus (HIV-1) in treatment-experienced adult patients with no darunavir [...]
No Comments »
Filed under: Pharmacy News
